Singapore markets closed
Straits Times Index
3,330.77 -0.04 (-0.00%) Nikkei
38,683.93 -19.58 (-0.05%) Hang Seng
18,366.95 -109.85 (-0.59%) FTSE 100
8,245.37 -39.97 (-0.48%) Bitcoin USD
71,001.59 +125.73 (+0.18%) CMC Crypto 200
1,481.58 +2.88 (+0.19%)
Esperion Therapeutics, Inc. (0ET.F)
Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
As of 09:06AM CEST. Market open.
Currency in EUR
Valuation measures4
| Market cap (intra-day) | 430.35M |
| Enterprise value | 469.33M |
| Trailing P/E | N/A |
| Forward P/E | 9.17 |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 1.20 |
| Price/book (mrq) | 86.74 |
| Enterprise value/revenue | 2.22 |
| Enterprise value/EBITDA | N/A |
Trading information
Stock price history
| Beta (5Y monthly) | 0.99 |
| 52-week change 3 | 56.79% |
| S&P500 52-week change 3 | 24.52% |
| 52-week high 3 | 2.9880 |
| 52-week low 3 | 0.6660 |
| 50-day moving average 3 | 2.0279 |
| 200-day moving average 3 | 1.7199 |
Share statistics
| Avg vol (3-month) 3 | 141 |
| Avg vol (10-day) 3 | 200 |
| Shares outstanding 5 | 189.46M |
| Implied shares outstanding 6 | 221.72M |
| Float 8 | 174.52M |
| % held by insiders 1 | 0.52% |
| % held by institutions 1 | 66.46% |
| Shares short 4 | N/A |
| Short ratio 4 | N/A |
| Short % of float 4 | N/A |
| Short % of shares outstanding 4 | N/A |
| Shares short (prior month ) 4 | N/A |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Currency in USD.Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | -37.65% |
| Operating margin (ttm) | 52.47% |
Management effectiveness
| Return on assets (ttm) | -6.94% |
| Return on equity (ttm) | N/A |
Income statement
| Revenue (ttm) | 229.74M |
| Revenue per share (ttm) | 1.83 |
| Quarterly revenue growth (yoy) | 466.10% |
| Gross profit (ttm) | N/A |
| EBITDA | -34.56M |
| Net income avi to common (ttm) | -86.51M |
| Diluted EPS (ttm) | -0.8300 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 226.61M |
| Total cash per share (mrq) | 1.2 |
| Total debt (mrq) | 548.87M |
| Total debt/equity (mrq) | N/A |
| Current ratio (mrq) | 2.22 |
| Book value per share (mrq) | -1.57 |
Cash flow statement
| Operating cash flow (ttm) | -27.3M |
| Levered free cash flow (ttm) | -45.36M |
© 2024 Yahoo. All rights reserved.